During the past decade, Sint-Trudo Ziekenhuis conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 1 clinical trials were completed, i.e. on average, 8.3% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sint-Trudo Ziekenhuis" #1 sponsor was "Hasselt University" with 4 trials, followed by "Cell Genesys" with 2 trials sponsored, "KU Leuven" with 2 trials sponsored, "Amgen" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sint-Trudo Ziekenhuis" #1 collaborator was "Sint-Trudo Hospital" with 3 trials as a collaborator, "Ziekenhuis Oost-Limburg" with 3 trials as a collaborator, "Jessa Hospital" with 2 trials as a collaborator, "Algemeen Ziekenhuis Maria Middelares" with 1 trials as a collaborator and "Algemeen Ziekenhuis Vesalius" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Sint-Trudo Ziekenhuis" are "Management Systems" (2 trials), "Prostate Cancer" (2 trials), "Public Health" (2 trials), "Quality Improvement" (2 trials) and "Atherosclerotic Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Sint-Trudo Ziekenhuis" in a lesser frequency.

Most popular intervention types in "Sint-Trudo Ziekenhuis" are "Other" (6 trials), "Drug" (5 trials), "Biological" (3 trials), "Device" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials), "Blood sampling" (1 trials), "Chemotherapy (Taxotere and prednisone)" (1 trials), "Chemotherapy (docetaxel and prednisone)" (1 trials) and "Convalescent Plasma" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sint-Trudo Ziekenhuis" are 11 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Sint-Trudo Ziekenhuis". undefined are not yet recruiting, 7 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in Sint-Trudo Ziekenhuis, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Sint-Trudo Ziekenhuis, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".